CHICAGO, May 29 /PRNewswire/ -- Spirus Medical, Inc. (www.spirusmed.com), a leading developer of diagnostic and therapeutic advancement systems for gastroenterology, urology and gynecology, announced that physicians using its Endo-Ease(TM) line of devices have performed complete examinations of the small intestine, or pan-endoscopy. Spirus is presenting at Digestive Disease Week 2009 in Chicago, May 30 through June 4.
Complete examination of the small intestine has been elusive in regular practice due to the difficulty in maneuvering an endoscope through the long, tortuous path in the body. The small intestine is about 20 to 23 feet long and other methods for reaching and studying its full length, whether starting through the mouth (antegrade) or the colon (retrograde), have proven challenging.
Spirus Medical has developed the Endo-Ease line of devices aimed at revolutionizing GI endoscopy. A patented spiral "over-tube" promotes faster, easier advancement of an endoscope, which helps physicians better examine and treat upper and lower GI disorders. Spiral enteroscopy allows for rapid small bowel access which can give the physician the ability to diagnosis and treat immediately, rather than the patient coming back for a second endoscopic and/or surgical procedure.
Recently, a pan-endoscopy was completed under conscious sedation by Dr. Stephen Hughes at Southmead Hospital in Bristol, England. Drs. Khaled Zachariah and Peter Marden were among those present for the case, which was performed using a slim enteroscope with the Endo-Ease Discovery SB(R) over-tube from an antegrade approach. Using the spiral enteroscopy technique, the medical team was able to traverse the small bowel and reach the ileo-cecal valve in 44 minutes.
A second pan-endoscopy was completed in two procedures by Dr. Luis Lara at the
SOURCE Spirus Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved
Related medicine technology :
1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study